Magnetic resonance spectroscopy in Alzheimer’s disease
Jonathan Graff-Radford,1 Kejal Kantarci21Department of Neurology, 2Department of Radiology, Mayo Clinic, Rochester, MN, USAAbstract: Aging is the primary risk factor for dementia. With increasing life expectancy and aging populations worldwide, dementia is becoming one of the significant public heal...
Enregistré dans:
Auteurs principaux: | Graff-Radford J, Kantarci K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/641a62ce47cf4e26bb4a41e7eddbcb55 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Neuroinflammation in Alzheimer’s disease
par: Zhang FJ, et autres
Publié: (2015) -
Update on the use of memantine in Alzheimer’s disease
par: Robert J van Marum
Publié: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
par: Kristinsson J, et autres
Publié: (2012) -
Activation of mTOR: a culprit of Alzheimer’s disease?
par: Cai Z, et autres
Publié: (2015) -
Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
par: Koppel J, et autres
Publié: (2014)